Vimarsana
Biggest News Aggregation in the World

Page 5 - Prosight Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prosight Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prosight Management Today - Breaking & Trending Today

Prosight Management LP Boosts Stock Position in ADC Therapeutics SA (NYSE:ADCT) - Vimarsana News

Prosight Management LP Boosts Stock Position in ADC Therapeutics SA (NYSE:ADCT)

Prosight Management LP lifted its holdings in ADC Therapeutics SA (NYSE:ADCT – Free Report) by 603.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,257,360 shares of the company’s stock after purchasing an additional 2,794,050 shares during the quarter. ADC Therapeutics accounts for […]

Prosight Management LP Trims Holdings in Alkermes plc (NASDAQ:ALKS) - Vimarsana News

Prosight Management LP Trims Holdings in Alkermes plc (NASDAQ:ALKS)

Prosight Management LP lowered its holdings in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 7.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 316,165 shares of the company’s stock after selling 25,356 shares during the period. Alkermes comprises about 4.2% of Prosight […]

Prosight Management LP Sells 381,667 Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) - Vimarsana News

Prosight Management LP Sells 381,667 Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)

Prosight Management LP cut its holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 61.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 240,000 shares of the specialty pharmaceutical company’s stock after selling 381,667 shares during the quarter. KalVista Pharmaceuticals comprises […]

Cantor Fitzgerald Reaffirms Overweight Rating for Aziyo Biologics (NASDAQ:AZYO) - Vimarsana News

Cantor Fitzgerald Reaffirms Overweight Rating for Aziyo Biologics (NASDAQ:AZYO)

Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $8.00 target price on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 436.91% from the company’s previous close. […]

Prosight Management LP Buys Shares of 1,179,090 Erasca, Inc. (NASDAQ:ERAS) - Vimarsana News

Prosight Management LP Buys Shares of 1,179,090 Erasca, Inc. (NASDAQ:ERAS)

Prosight Management LP purchased a new position in Erasca, Inc. (NASDAQ:ERAS – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor purchased 1,179,090 shares of the company’s stock, valued at approximately $3,549,000. Erasca makes up about 1.7% of Prosight Management LP’s holdings, making the stock its 26th largest holding. Other hedge funds and […]